MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion

A. Zhao, Y. Jiao, J. Liu, Y. Li (shanghai, China)

Meeting: 2025 International Congress

Keywords: Microglia, Parkinson’s

Category: Parkinson's Disease: Pathophysiology / molecular mechanisms of disease

Objective: DJ-1, also known as Parkinson’s disease protein 7 (PARK7), is a multifunctional protein that is important in regulating oxidative stress and neuroprotection.

Background: The imbalance of neuronal-microglia “crosstalk” participates in the pathogenesis of Parkinson’s disease (PD), in which CX3CL1/CX3CR1 axis plays an important role. However, the specific regulatory mechanism of CX3CL1 and its role in microglia polarization remains elusive. The aim of this study was to explore the regulatory mechanisms of DJ-1 on CX3CL1/CX3CR1 to further investigate its relationship with neuroinflammation.

Method: We explored the correlation between DJ-1 and CX3CL1 and their role of neuroinflammation in MPTP-induced PD mice, DJ-1 -/- mice primary microglia, primary mesencephalic neurons, SH-SY5Y and BV-2 cell lines. We also explored the molecular mechanisms of these interactions and the signaling processes involved in neuroinflammation.

Results: We confirmed the positive correlation between DJ-1 and CX3CL1 in the serum of PD patients and MPTP PD models. With DJ-1 downregulation, CX3CL1 could inhibit the microglial activation, promote the M1 to M2 phenotype conversion, and reduce the inflammatory factors release. In addition, DJ-1 mediated CX3CL1 regulation by interfering with the shedding and maturation of ADAM10 at endoplasmic reticulum (ER) sites on neurons.

Conclusion: Our study suggests that reduced DJ-1 expression in neurons interfered with the shear maturation of ADAM10 in the ER to inhibit the membrane shear release of CX3CL1, thereby resulting in microglial activation and phenotypic transformation in a pro-inflammatory environment. This project clarifies the role of neuronal DJ-1 in regulating the CX3CL1/CX3CR1 axis and thus directly regulating microglia polarization to provide a new target for immune intervention in PD.

To cite this abstract in AMA style:

A. Zhao, Y. Jiao, J. Liu, Y. Li. Neuronal DJ-1 regulates microglia activation via ADAM10-mediated CX3CL1 secretion [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/neuronal-dj-1-regulates-microglia-activation-via-adam10-mediated-cx3cl1-secretion/. Accessed November 20, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/neuronal-dj-1-regulates-microglia-activation-via-adam10-mediated-cx3cl1-secretion/

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley